Abstract
Objective: The sulphation of the neurotransmitters dopamine and 5-hydroxytryptamine, and of the prototypical xenobiotic 4-nitrophenol, by phenolsulphotransferases was measured in platelet homogenates prepared from a group of migraine sufferers and a group of control subjects.
Results: The activity of the M form of phenolsulpho-transferase, responsible for the sulphation of dopamine and 5-hydroxytryptamine was significantly reduced in the migraine population, by 28% with dopamine as substrate and by 20% with 5-hydroxytryptamine. The activity of the P form of the enzyme towards 4-nitrophenol was the same in both groups. We also report that the selective inhibition of P form phenolsulpho-transferase by red wine is much more potent than previously thought, with a 2000-fold dilution of dealcoholised red wine having the ability to inhibit sulphation by this enzyme by 50%.
Conclusion: Our findings suggest that a reduced capacity for sulphation and inactivation of biogenic amines and catecholamines may be related to susceptibility to migraine.
Similar content being viewed by others
Abbreviations
- 5-HT:
-
5-hydroxytryptamine
- ST:
-
sulphotransferase
- PST:
-
phenolsulphotransferase
- M-PST:
-
monoamine-sulphating form of phenolsulphotransferase
- P-PST:
-
phenol-sulphating form of phenolsulphotransferase
- PAPS:
-
3′-phosphadenosine 5′-phosphosulphate
- IC50 :
-
concentration resulting in 50% inhibition of enzyme activity.
References
Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States JAMA 267:64–69
Selby G, Lance JW (1960) Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 23:23–32
Joutel A, Bousser M-G, Biousse V, Labauge P, Chabriat H, Nibbio A, Maciazek J, Meyer B, Bach A-M, Weissenbach J, Lathrop GM, Tournier-Lasserve E (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nature Genetics 5:40–45
Humphrey PPA, Feniuk W, Perren MJ, Beresford IJM, Skingle M, Whalley, ET (1990) Serotonin and migraine. Ann New York Acad Sci 600:587–600
Oleson J, Edvinsson L (1991) Migraine: a research field matured for the basic neurosciences. Trends Neurosci 14:3–5
Humphrey PPA, Feniuk W, Perren MJ, Conner HE, Oxford AW (1989) The pharmacology of the novel 5-HT1-like receptor agonist, GR43175. Cephalalgia 9 [Suppl 9]:23–33
Falany CN (1991) Molecular enzymology of human liver cytosolic sulfotransferases Trends Pharmacol Sci 12:255–259
Jakoby WB, Sekura RD, Lyon ES, Marcus CJ, Wang J-L (1980) Sulfotransferases. In: Jakoby WB (ed) Enzymatic Basis of Detoxication Volume 2. Academic Press, New York, pp 199–228
Weinshilboum R, Otterness D (1994) Sulfotransferase enzymes. In: Kauffman FC (ed) Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Springer, Berlin, pp 45–78
Forbes-Bamforth KJ, Coughtrie MWH (1994) Identification of a new adult human liver sulfotransferase with specificity for endogenous and xenobiotic estrogens. Biochem Biophys Res Commun 198:707–711
Aksoy IA, Wood TC, Weinshilboum R (1994) Human liver estrogen sulfotransferase: Identification by cDNA cloning and expression. Biochem Biophys Res Commun 200:1621–1629
Johnson GA, Baker CA, Smith, RT (1980) Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma. Life Sci 26:1591–1598
Bamforth KJ, Jones AL, Roberts RC, Coughtrie MWH (1993) Common food additives are potent inhibitors of human liver 17α-ethinyloestradiol and dopamine sulphotransferases. Biochem Pharmacol 46:1713–1720
Campbell NRC, van Loon JA, Weinshilboum RM (1987) Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem Pharmacol 36:1435–1446
Heroux JA, Roth JA (1988) Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets. Mol Pharmacol 34:194–199
Falany CN, Vazquez ME, Heroux JA, Roth JA (1990) Purification and characterization of human liver phenol-sulfating phenol sulfotransferase Arch Biochem Biophys 278:312–318
Littlewood J, Glover V, Sandler M, Petty R, Peatfield R, Rose FC (1982) Platelet phenolsulphotransferase deficiency in dietary migraine. Lancet 1:983–985
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 [Suppl 7]:19–28
Foldes A, Meek JL (1973) Rat brain phenolsulphotransferase — partial purification and some properties. Biochim Biophys Acta 327:365–374
Lowry OH, Rosebrough NJ, Farr AL Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Wood TC, Aksoy IA, Aksoy S, Weinshilboum RM (1994) Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. Biochem Biophys Res Commun 198:1119–1127
Cohen ML (1984) Vascular serotonin receptors and blood pressure regulation. Drug Dev Res 4:301–313
Hanington E (1980) Diet and Migraine. J Hum Nutr 34:175–180
Littlewood JT, Glover V, Daviels PTG, Gibb C, Sandler M, Rose FC (1988) Red wine as a cause of migraine. Lancet 1:558–559
Gibb C, Glover V, Sandler M (1987) In vitro inhibition of phenolsulphotransferase by food and drink constituents. Biochem Pharmacol 36:2325–2330
Littlewood JT, Glover V, Sandler M (1985) Red wine contains a potent inhibitor of phenolsulphotransferase. Br J Clin Pharmacol 19:275–278
Lönnqvist B, Ringdén, O. (1990) Migraine precipitated by red wine after bone-marrow transplantation. Lancet 335:364
Jones AL, Roberts RC, Coughtrie MWH (1993) The human phenolsulphotransferase polumorphism is determined by the level of expression of enzyme protein. Biochem J 296:287–290
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, A.L., Rubin, G.L., Coughtrie, M.W.H. et al. Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine. Eur J Clin Pharmacol 49, 109–114 (1995). https://doi.org/10.1007/BF00192368
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00192368